Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 1
2007 2
2008 2
2009 1
2010 1
2011 9
2012 15
2013 12
2014 14
2015 13
2016 14
2017 14
2018 8
2019 7
2020 14
2021 17
2022 13
2023 14
2024 17
2025 17
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
Walsh M, Merkel PA, Peh CA, Szpirt WM, Puéchal X, Fujimoto S, Hawley CM, Khalidi N, Floßmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Suárez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW; PEXIVAS Investigators. Walsh M, et al. N Engl J Med. 2020 Feb 13;382(7):622-631. doi: 10.1056/NEJMoa1803537. N Engl J Med. 2020. PMID: 32053298 Free PMC article. Clinical Trial.
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodríguez AF, González-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Díaz González-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM. Palmer SC, et al. Among authors: badve sv. BMJ. 2021 Jan 13;372:m4573. doi: 10.1136/bmj.m4573. BMJ. 2021. PMID: 33441402 Free PMC article.
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
Inker LA, Collier W, Greene T, Miao S, Chaudhari J, Appel GB, Badve SV, Caravaca-Fontán F, Del Vecchio L, Floege J, Goicoechea M, Haaland B, Herrington WG, Imai E, Jafar TH, Lewis JB, Li PKT, Maes BD, Neuen BL, Perrone RD, Remuzzi G, Schena FP, Wanner C, Wetzels JFM, Woodward M, Heerspink HJL; CKD-EPI Clinical Trials Consortium. Inker LA, et al. Among authors: badve sv. Nat Med. 2023 Jul;29(7):1867-1876. doi: 10.1038/s41591-023-02418-0. Epub 2023 Jun 17. Nat Med. 2023. PMID: 37330614 Free PMC article.
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials.
Lee MMY, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter NR, Badve SV, Pratley RE, Perkovic V, Buse JB, McGuire DK; SOUL Trial Investigators. Lee MMY, et al. Among authors: badve sv. Diabetes Care. 2025 May 1;48(5):846-859. doi: 10.2337/dc25-0241. Diabetes Care. 2025. PMID: 40156846
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Neuen BL, Fletcher RA, Heath L, Perkovic A, Vaduganathan M, Badve SV, Tuttle KR, Pratley R, Gerstein HC, Perkovic V, Heerspink HJL. Neuen BL, et al. Among authors: badve sv. Circulation. 2024 Nov 26;150(22):1781-1790. doi: 10.1161/CIRCULATIONAHA.124.071689. Epub 2024 Aug 30. Circulation. 2024. PMID: 39210781
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Singh AK, Carroll K, Perkovic V, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Więcek A, Blackorby A, Cizman B, Cobitz AR, Davies R, Dole J, Kler L, Meadowcroft AM, Zhu X, McMurray JJV; ASCEND-D Study Group. Singh AK, et al. N Engl J Med. 2021 Dec 16;385(25):2325-2335. doi: 10.1056/NEJMoa2113379. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739194 Free article. Clinical Trial.
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
Singh AK, Carroll K, McMurray JJV, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Więcek A, Blackorby A, Cizman B, Cobitz AR, Davies R, DiMino TL, Kler L, Meadowcroft AM, Taft L, Perkovic V; ASCEND-ND Study Group. Singh AK, et al. N Engl J Med. 2021 Dec 16;385(25):2313-2324. doi: 10.1056/NEJMoa2113380. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739196 Free article. Clinical Trial.
Editor's note.
Badve SV. Badve SV. Intern Med J. 2021 Aug;51(8):1368. doi: 10.1111/imj.15462. Epub 2021 Aug 6. Intern Med J. 2021. PMID: 34355849 No abstract available.
Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial.
Harel Z, Smyth B, Badve SV, Blum D, Beaubien-Souligny W, Silver SA, Clark E, Suri R, Mavrakanas TA, Sasal J, Prasad B, Eikelboom J, Tennankore K, Rigatto C, Prce I, Madore F, Mac-Way F, Steele A, Zeng Y, Sholzberg M, Dorian P, Yan AT, Sood MM, Gladstone DJ, Tseng E, Kitchlu A, Walsh M, Sapir D, Oliver MJ, Krishnan M, Kiaii M, Wong N, Kotwal S, Battistella M, Acedillo R, Lok C, Weir M, Wald R. Harel Z, et al. Among authors: badve sv. J Am Soc Nephrol. 2025 May 1;36(5):901-910. doi: 10.1681/ASN.0000000000000495. Epub 2024 Nov 4. J Am Soc Nephrol. 2025. PMID: 39495569 Free PMC article.
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.
Badve SV, Perkovic V, Jha V, Ramachandran R, Mushahar L, Menne J, De Vriese AS, Rossignol P, Flahault A, Al Ammari M, Skhiri H, Walsh M, Collister D, Liew A, Billot L, Bompoint S, Devaux A, Jun M, Lin E, Ramos da Cruz A, Ha JT, Eikelboom JW, Shaman A, Jardine MJ, Jesudason S, Wong MG, Anderson CS, Garg AX, Heerspink HJL, Monaghan H, Patel A, Mark PB, Wheeler DC, Lv J, Zuo L, Pilmore H, Gallagher M; TRACK Trial Investigators. Badve SV, et al. JAMA. 2026 Jun 4:e269379. doi: 10.1001/jama.2026.9379. Online ahead of print. JAMA. 2026. PMID: 42240165
Breast Cancer and Transplantation.
Wong G, Au E, Badve SV, Lim WH. Wong G, et al. Among authors: badve sv. Am J Transplant. 2017 Sep;17(9):2243-2253. doi: 10.1111/ajt.14368. Epub 2017 Aug 1. Am J Transplant. 2017. PMID: 28544474 Free article. Review.
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease.
Bakker WM, Heerspink HJL, Berger SP, Wanner C, Badve SV, Arnott C, Abrahams AC, van den Born JC, van Faassen TC, Gaillard CAJM, Gelens MACJ, Górris JL, Hemmelder MH, Jakulj L, van Kruijsdijk RCM, Kuypers DRJ, van der Meer P, van der Net JB, Nijmeijer HH, Vervloet MG, de Vries APJ, Walsh M, Wang AY, Gansevoort RT; Renal Lifecycle Trial Investigators. Bakker WM, et al. Among authors: badve sv. Nephrol Dial Transplant. 2025 Aug 29;40(9):1746-1755. doi: 10.1093/ndt/gfaf046. Nephrol Dial Transplant. 2025. PMID: 40053493 Free PMC article.
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.
Odler B, Riedl R, Geetha D, Szpirt WM, Hawley C, Uchida L, Wallace ZS, Walters G, Muso E, Tesar V, Pusey CD, Little MA, Merkel PA, Walsh M, Jayne DRW, Kronbichler A; PEXIVAS Investigators. Odler B, et al. Kidney Int. 2025 Mar;107(3):558-567. doi: 10.1016/j.kint.2024.11.029. Epub 2024 Dec 19. Kidney Int. 2025. PMID: 39708998 Free article. Clinical Trial.
Effects of Allopurinol on the Progression of Chronic Kidney Disease.
Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, de Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, Jones GRD, Kanellis J, Palmer SC, Perkovic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW; CKD-FIX Study Investigators. Badve SV, et al. N Engl J Med. 2020 Jun 25;382(26):2504-2513. doi: 10.1056/NEJMoa1915833. N Engl J Med. 2020. PMID: 32579811 Clinical Trial.
Canagliflozin and iron metabolism in the CREDENCE trial.
Koshino A, Heerspink HJL, Jongs N, Badve SV, Arnott C, Neal B, Jardine M, Mahaffey KW, Pollock C, Perkovic V, Hansen MK, Bakker SJL, Wada T, Neuen BL. Koshino A, et al. Among authors: badve sv. Nephrol Dial Transplant. 2025 Apr 1;40(4):696-706. doi: 10.1093/ndt/gfae198. Nephrol Dial Transplant. 2025. PMID: 39304530 Free PMC article. Clinical Trial.
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression.
Greene T, Collier W, Haaland B, Zhang C, Badve SV, Caravaca-Fontán F, Del Vecchio L, Floege J, Hannedouche T, Imai E, Jafar TH, Lewis JB, Li PKT, Locatelli F, Maes BD, Neuen BL, Perrone RD, Schena FP, Toto R, Wanner C, Woodward M, van Zuilen A, Heerspink HJL, Inker LA; CKD-EPI Clinical Trials Consortium. Greene T, et al. Among authors: badve sv. Clin J Am Soc Nephrol. 2025 May 1;20(5):632-641. doi: 10.2215/CJN.0000000662. Epub 2025 Apr 15. Clin J Am Soc Nephrol. 2025. PMID: 40237639 Free PMC article.
Allopurinol and Chronic Kidney Disease. Reply.
Badve SV, Pascoe EM. Badve SV, et al. N Engl J Med. 2020 Oct 22;383(17):1691-1692. doi: 10.1056/NEJMc2026125. N Engl J Med. 2020. PMID: 33085877 No abstract available.
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD.
Chan B, Varghese A, Badve SV, Pecoits-Filho R, Guedes M, Arnott C, Kozor R, O'Lone E, Jun M, Kotwal S, Block GA, Chertow GM, Solomon SD, Vaduganathan M, Perkovic V, Neuen BL. Chan B, et al. Among authors: badve sv. Kidney Int Rep. 2025 Jan 29;10(4):1037-1049. doi: 10.1016/j.ekir.2025.01.029. eCollection 2025 Apr. Kidney Int Rep. 2025. PMID: 40303218 Free PMC article.
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset.
Wallace H, Wick J, Neuen BL, Buizen L, Badve SV, Chalmers J, de Oliveira Costa J, Falster MO, Ha JT, Jardine MJ, Ketema DB, Lin J, Nelson C, Pearson SA, Peiris D, Rodgers A, Sasaki T, Woodward M, Gallagher M, Kotwal SS, Ronksley P, Jun M. Wallace H, et al. Among authors: badve sv. Diabetes Obes Metab. 2025 Oct;27(10):5599-5611. doi: 10.1111/dom.16608. Epub 2025 Jul 16. Diabetes Obes Metab. 2025. PMID: 40667713 Free PMC article.
Biocompatible dialysis fluids for peritoneal dialysis.
Htay H, Johnson DW, Wiggins KJ, Badve SV, Craig JC, Strippoli GF, Cho Y. Htay H, et al. Among authors: badve sv. Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3. Cochrane Database Syst Rev. 2018. PMID: 30362116 Free PMC article.
SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2.
Chatur S, Fletcher RA, Yeung E, Siriwardana A, Heath L, Vaduganathan M, Arnott C, Badve SV, Kotwal S, Jun M, Jardine M, Pollock C, Heerspink HJ, Perkovic V, Neuen BL. Chatur S, et al. Among authors: badve sv. J Card Fail. 2026 Feb 27:S1071-9164(26)00106-5. doi: 10.1016/j.cardfail.2026.01.020. Online ahead of print. J Card Fail. 2026. PMID: 41765341 Free article.
Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies.
Karsten M, Badve SV, Gansevoort RT, Berger SP, Heerspink HJL, Abrahams AC, Billot L, Bon RHACM, Gelens MACJ, Guinness D, Hamilton-Craig C, van Heerebeek L, Hemmelder MH, Houston L, Kozor R, Kuypers DRJ, Monaghan H, Neal B, Neuen BL, Otton J, Perkovic V, Rajwani A, Wang AY, Vervloet MG, Arnott C, Jakulj L; Renal Lifecycle Trial Cardiac Imaging Sub-studies Investigators. Karsten M, et al. Among authors: badve sv. Clin Kidney J. 2025 Dec 2;19(1):sfaf376. doi: 10.1093/ckj/sfaf376. eCollection 2026 Jan. Clin Kidney J. 2025. PMID: 41551843 Free PMC article.
Interventions for erythropoietin-resistant anaemia in dialysis patients.
Badve SV, Beller EM, Cass A, Francis DP, Hawley C, Macdougall IC, Perkovic V, Johnson DW. Badve SV, et al. Cochrane Database Syst Rev. 2013 Aug 26;2013(8):CD006861. doi: 10.1002/14651858.CD006861.pub3. Cochrane Database Syst Rev. 2013. PMID: 23979995 Free PMC article.
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based Study.
Lam D, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M, Ha JT. Lam D, et al. Among authors: badve sv. Kidney360. 2025 Sep 1;6(9):1510-1521. doi: 10.34067/KID.0000000809. Epub 2025 Apr 9. Kidney360. 2025. PMID: 40202804 Free PMC article.
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.
Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW. Bose B, et al. Among authors: badve sv. Nephrol Dial Transplant. 2014 Feb;29(2):406-13. doi: 10.1093/ndt/gft378. Epub 2013 Sep 15. Nephrol Dial Transplant. 2014. PMID: 24042021
Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease.
Rangan GK, Wong ATY, Munt A, Zhang JQJ, Saravanabavan S, Louw S, Allman-Farinelli M, Badve SV, Boudville N, Chan J, Coolican H, Coulshed S, Edwards ME, Erickson BJ, Fernando M, Foster S, Gregory AV, Haloob I, Hawley CM, Holt J, Howard K, Howell M, Johnson DW, Kline TL, Kumar K, Lee VW, Lonergan M, Mai J, McCloud P, Pascoe E, Peduto A, Rangan A, Roger SD, Sherfan J, Sud K, Torres VE, Vilayur E, Harris DCH. Rangan GK, et al. Among authors: badve sv. NEJM Evid. 2022 Jan;1(1):EVIDoa2100021. doi: 10.1056/EVIDoa2100021. Epub 2021 Nov 4. NEJM Evid. 2022. PMID: 38319283 Clinical Trial.
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.
Badve SV, Al Ammari M, Anderson CS, Billot L, Bompoint S, Collister D, De Vriese AS, Eikelboom JW, Flahault A, Garg AX, Ha JT, Heerspink HJL, Jardine MJ, Jesudason S, Jha V, Jun M, Landrigan J, Liew A, Lin E, Lv J, Mark PB, Menne J, Monaghan H, Mushahar L, Patel A, Pilmore H, Perkovic V, Ramachandran R, Rossignol P, Shaman A, Skhiri H, Walsh M, Wheeler DC, Wong MG, Zuo L, Gallagher M. Badve SV, et al. Am J Nephrol. 2026 Feb 9:1-11. doi: 10.1159/000550796. Online ahead of print. Am J Nephrol. 2026. PMID: 41662295
Biocompatible peritoneal dialysis fluids: clinical outcomes.
Cho Y, Badve SV, Hawley CM, Wiggins K, Johnson DW. Cho Y, et al. Among authors: badve sv. Int J Nephrol. 2012;2012:812609. doi: 10.1155/2012/812609. Epub 2012 Nov 28. Int J Nephrol. 2012. PMID: 23251801 Free PMC article.
International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival.
Davies S, Zhao J, McCullough KP, Kim YL, Wang AY, Badve SV, Mehrotra R, Kanjanabuch T, Kawanishi H, Robinson B, Pisoni R, Perl J; PDOPPS Dialysis Prescription and Fluid Management Working Group. Davies S, et al. Among authors: badve sv. Kidney360. 2022 Mar 1;3(5):872-882. doi: 10.34067/KID.0006922021. eCollection 2022 May 26. Kidney360. 2022. PMID: 36128496 Free PMC article.
Challenges in blood pressure measurement in patients treated with maintenance hemodialysis.
Roberts MA, Pilmore HL, Tonkin AM, Garg AX, Pascoe EM, Badve SV, Cass A, Ierino FL, Hawley CM; Beta-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study Trial Management Committee. Roberts MA, et al. Among authors: badve sv. Am J Kidney Dis. 2012 Sep;60(3):463-72. doi: 10.1053/j.ajkd.2012.04.026. Epub 2012 Jun 15. Am J Kidney Dis. 2012. PMID: 22704141 Review.
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis.
Li C, Yu J, Hockham C, Perkovic V, Neuen BL, Badve SV, Houston L, Lee VYJ, Barraclough JY, Fletcher RA, Mahaffey KW, Heerspink HJL, Cannon CP, Neal B, Arnott C. Li C, et al. Among authors: badve sv. Diabetes Obes Metab. 2022 Oct;24(10):1927-1938. doi: 10.1111/dom.14772. Epub 2022 Jun 9. Diabetes Obes Metab. 2022. PMID: 35589614
Representativeness of the PDOPPS cohort compared to the Australian PD population.
Ethier I, Boudville N, McDonald S, Brown F, Kerr PG, Walker R, Holt SG, Badve SV, Cho Y, Hawley C, Robison L, Reidlinger D, Milanzi E, Bieber B, McCullough K, Johnson DW. Ethier I, et al. Among authors: badve sv. Perit Dial Int. 2022 Jul;42(4):403-414. doi: 10.1177/08968608211056242. Epub 2021 Nov 10. Perit Dial Int. 2022. PMID: 34758648
Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes.
Neuen BL, Ostrominski JW, Claggett B, Beldhuis IE, Chatur S, McCausland FR, Badve SV, Arnott C, Heerspink HJL, Jun M, Falster M, de Oliveira Costa J, Pollock C, Jardine MJ, Mahaffey KW, Perkovic V, Solomon SD, Vaduganathan M. Neuen BL, et al. Among authors: badve sv. J Am Coll Cardiol. 2024 Nov 26;84(22):2246-2250. doi: 10.1016/j.jacc.2024.08.006. Epub 2024 Aug 31. J Am Coll Cardiol. 2024. PMID: 39217558 Free article. No abstract available.
Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease.
Amin S, Sangadi I, Allman-Farinelli M, Badve SV, Boudville N, Coolican H, Coulshed S, Foster S, Fernando M, Haloob I, Harris DCH, Hawley CM, Holt J, Howell M, Kumar K, Johnson DW, Lee VW, Mai J, Rangan A, Roger SD, Sud K, Torres V, Vilayur E, Rangan GK. Amin S, et al. Among authors: badve sv. Kidney Med. 2023 Jun 29;5(9):100691. doi: 10.1016/j.xkme.2023.100691. eCollection 2023 Sep. Kidney Med. 2023. PMID: 37602144 Free PMC article.
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD.
Collier W, Inker LA, Haaland B, Appel GB, Badve SV, Caravaca-Fontán F, Chalmers J, Floege J, Goicoechea M, Imai E, Jafar TH, Lewis JB, Li PKT, Locatelli F, Maes BD, Neuen BL, Perrone RD, Remuzzi G, Schena FP, Wanner C, Heerspink HJL, Greene T; Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)*. Collier W, et al. Among authors: badve sv. Clin J Am Soc Nephrol. 2023 Feb 1;18(2):183-192. doi: 10.2215/CJN.0000000000000050. Epub 2023 Jan 19. Clin J Am Soc Nephrol. 2023. PMID: 36754007 Free PMC article.
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study.
Jun M, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Ha J, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M. Jun M, et al. Among authors: badve sv. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):621-631. doi: 10.1093/ehjqcco/qcac069. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 36302143 Free article.
The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.
Badve SV, Palmer SC, Strippoli GFM, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath SS, Pascoe EM, Perkovic V, Whalley GA, Craig JC, Johnson DW. Badve SV, et al. Am J Kidney Dis. 2016 Oct;68(4):554-563. doi: 10.1053/j.ajkd.2016.03.418. Epub 2016 Apr 30. Am J Kidney Dis. 2016. PMID: 27138469
Frequent versus standard hemodialysis.
Badve SV, Hawley CM, Johnson DW. Badve SV, et al. N Engl J Med. 2011 Mar 10;364(10):975; author reply 976. doi: 10.1056/NEJMc1100105. N Engl J Med. 2011. PMID: 21388319 No abstract available.
Glomerular disease registry and biobank: design and baseline results.
Jeyaruban A, Bose B, Lee VW, Jardine M, Mallawaarachchi A, Ritchie A, Wong MG, Makris A, Badve SV, Siriwardana A, Yong K, Perkovic V, Kotwal S. Jeyaruban A, et al. Among authors: badve sv. Intern Med J. 2025 Aug;55(8):1301-1307. doi: 10.1111/imj.70056. Epub 2025 Apr 11. Intern Med J. 2025. PMID: 40214285
Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice.
Viecelli AK, Teixeira-Pinto A, Valks A, Baer R, Cherian R, Cippà PE, Craig JC, DeSilva R, Jaure A, Johnson DW, Kiriwandeniya C, Kopperschmidt P, Liu WJ, Lee T, Lok C, Madhan K, Mallard AR, Oliver V, Polkinghorne KR, Quinn RR, Reidlinger D, Roberts M, Sautenet B, Hooi LS, Smith R, Snoeijs M, Tordoir J, Vachharajani TJ, Vanholder R, Vergara LA, Wilkie M, Yang B, Yuo TH, Zou L, Hawley CM; VALID Investigator Team. Viecelli AK, et al. BMC Nephrol. 2022 Nov 19;23(1):372. doi: 10.1186/s12882-022-02987-1. BMC Nephrol. 2022. PMID: 36402958 Free PMC article.
Outcomes of Corynebacterium Peritonitis: A Multicenter Registry Analysis.
Htay H, Cho Y, Pascoe EM, Darssan D, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW. Htay H, et al. Among authors: badve sv. Perit Dial Int. 2017 Nov-Dec;37(6):619-626. doi: 10.3747/pdi.2017.00028. Epub 2017 Jul 11. Perit Dial Int. 2017. PMID: 28698253
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada.
Ha JT, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Lam D, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M. Ha JT, et al. Among authors: badve sv. Kidney Med. 2023 May 16;5(7):100675. doi: 10.1016/j.xkme.2023.100675. eCollection 2023 Jul. Kidney Med. 2023. PMID: 37492112 Free PMC article.
The association between peritoneal dialysis modality and peritonitis.
Lan PG, Johnson DW, McDonald SP, Boudville N, Borlace M, Badve SV, Sud K, Clayton PA. Lan PG, et al. Among authors: badve sv. Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1091-7. doi: 10.2215/CJN.09730913. Epub 2014 Mar 13. Clin J Am Soc Nephrol. 2014. PMID: 24626434 Free PMC article.
Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD).
Madken M, Mallick R, Rhodes E, Mahdavi R, Bader Eddeen A, Hundemer GL, Kelly DM, Karaboyas A, Robinson B, Bieber B, Molnar AO, Badve SV, Tanuseputro P, Knoll G, Sood MM. Madken M, et al. Among authors: badve sv. Can J Kidney Health Dis. 2023 Jun 22;10:20543581231169610. doi: 10.1177/20543581231169610. eCollection 2023. Can J Kidney Health Dis. 2023. PMID: 37377481 Free PMC article.
Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW. Zhang L, et al. Among authors: badve sv. Kidney Int. 2016 Jun;89(6):1337-45. doi: 10.1016/j.kint.2016.02.014. Epub 2016 Apr 8. Kidney Int. 2016. PMID: 27165824 Free article.
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial.
Jun M, Harris K, Heerspink HJL, Badve SV, Jardine MJ, Harrap S, Hamet P, Marre M, Poulter N, Kotwal S, Gallagher M, Perkovic V, Chalmers J, Woodward M; ADVANCE Collaborative Group. Jun M, et al. Among authors: badve sv. Diabetes Obes Metab. 2021 Jun;23(6):1420-1425. doi: 10.1111/dom.14351. Epub 2021 Mar 4. Diabetes Obes Metab. 2021. PMID: 33606920
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).
Toussaint ND, Pedagogos E, Lioufas NM, Elder GJ, Pascoe EM, Badve SV, Valks A, Block GA, Boudville N, Cameron JD, Campbell KL, Chen SSM, Faull RJ, Holt SG, Jackson D, Jardine MJ, Johnson DW, Kerr PG, Lau KK, Hooi LS, Narayan O, Perkovic V, Polkinghorne KR, Pollock CA, Reidlinger D, Robison L, Smith ER, Walker RJ, Wang AYM, Hawley CM; IMPROVE-CKD Trial Investigators. Toussaint ND, et al. Among authors: badve sv. J Am Soc Nephrol. 2020 Nov;31(11):2653-2666. doi: 10.1681/ASN.2020040411. Epub 2020 Sep 11. J Am Soc Nephrol. 2020. PMID: 32917784 Free PMC article. Clinical Trial.
Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis-International Results from PDOPPS.
Davies SJ, Zhao J, Morgenstern H, Zee J, Bieber B, Fuller DS, Sloand JA, Vychytil A, Kawanishi H, Johnson DW, Wang AY, Kanjananbuch T, Boongird S, Moraes TP, Badve SV, Pisoni RL, Perl J; PDOPPS Dialysis Prescription and Fluid Management Working Group. Davies SJ, et al. Among authors: badve sv. Kidney Int Rep. 2020 Nov 22;6(2):313-324. doi: 10.1016/j.ekir.2020.11.021. eCollection 2021 Feb. Kidney Int Rep. 2020. PMID: 33615056 Free PMC article.
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial.
Hudson R, Pascoe EM, See YP, Cho Y, Polkinghorne KR, Paul-Brent PA, Hooi LS, Ong LM, Mori TA, Badve SV, Cass A, Kerr PG, Voss D, Hawley CM, Johnson DW, Irish AB, Viecelli AK. Hudson R, et al. Among authors: badve sv. J Vasc Access. 2024 Jan;25(1):193-202. doi: 10.1177/11297298221099134. Epub 2022 Jun 10. J Vasc Access. 2024. PMID: 35686506
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial.
Koshino A, Neuen BL, Oshima M, Toyama T, Hara A, Arnott C, Neal B, Jardine M, Badve SV, Mahaffey KW, Pollock C, Hansen MK, Wada T, Heerspink HJL. Koshino A, et al. Among authors: badve sv. Kidney Int Rep. 2023 Dec 1;9(2):347-355. doi: 10.1016/j.ekir.2023.11.024. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344715 Free PMC article.
Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data.
Neuen BL, Jun M, Wick J, Kotwal S, Badve SV, Jardine MJ, Gallagher M, Chalmers J, Nallaiah K, Perkovic V, Peiris D, Rodgers A, Woodward M, Ronksley PE. Neuen BL, et al. Among authors: badve sv. Lancet Reg Health West Pac. 2023 Dec 18;43:100988. doi: 10.1016/j.lanwpc.2023.100988. eCollection 2024 Feb. Lancet Reg Health West Pac. 2023. PMID: 38192747 Free PMC article.
EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS.
See EJ, Johnson DW, Hawley CM, Pascoe EM, Darssan D, Clayton PA, Borlace M, Badve SV, Sud K, Boudville NC, Cho Y. See EJ, et al. Among authors: badve sv. Perit Dial Int. 2017 Sep 28:pdi.2017.00029. doi: 10.3747/pdi.2017.00029. Online ahead of print. Perit Dial Int. 2017. PMID: 28970365
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study.
Lioufas N, Toussaint ND, Pedagogos E, Elder G, Badve SV, Pascoe E, Valks A, Hawley C; IMPROVE-CKD Writing Committee.. Lioufas N, et al. Among authors: badve sv. BMJ Open. 2019 Feb 21;9(2):e024382. doi: 10.1136/bmjopen-2018-024382. BMJ Open. 2019. PMID: 30796122 Free PMC article.
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S. Lo C, et al. Among authors: badve sv. Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jul 30;8:CD009966. doi: 10.1002/14651858.CD009966.pub3. PMID: 28238223 Free PMC article. Updated.
Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.
Roberts MA, Darssan D, Badve SV, Carroll RP, Fahim MA, Haluska BA, Hawley CM, Isbel NM, Marshall MR, Pascoe EM, Pedagogos E, Pilmore HL, Snelling P, Stanton T, Tan KS, Tonkin AM, Vergara LA, Ierino FL. Roberts MA, et al. Among authors: badve sv. Kidney Blood Press Res. 2017;42(6):1033-1044. doi: 10.1159/000485589. Epub 2017 Dec 4. Kidney Blood Press Res. 2017. PMID: 29197871 Free article. Clinical Trial.
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group. Viecelli AK, et al. Among authors: badve sv. PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019. PLoS One. 2019. PMID: 30913208 Free PMC article. Clinical Trial.
Cytomegalovirus nasal polyp after renal transplant.
Kulkarni AA, Badve SV, Tapiawala SN, Deshpande RB, Shah BV. Kulkarni AA, et al. Among authors: badve sv. J Assoc Physicians India. 2003 Jun;51:614-5. J Assoc Physicians India. 2003. PMID: 15266933
Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study.
Thirugnanasambathan T, Hawley CM, Badve SV, McDonald SP, Brown FG, Boudville N, Wiggins KJ, Bannister KM, Clayton P, Johnson DW. Thirugnanasambathan T, et al. Among authors: badve sv. Am J Kidney Dis. 2012 Jan;59(1):84-91. doi: 10.1053/j.ajkd.2011.06.018. Epub 2011 Aug 16. Am J Kidney Dis. 2012. PMID: 21849228
Dengue Fever and Takotsubo Cardiomyopathy.
Badve SV, Patil S, Rathod NM, Jumrani CK. Badve SV, et al. J Assoc Physicians India. 2015 Jul;63(7):67-70. J Assoc Physicians India. 2015. PMID: 26731834
Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.
Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group. Irish AB, et al. Among authors: badve sv. JAMA Intern Med. 2017 Feb 1;177(2):184-193. doi: 10.1001/jamainternmed.2016.8029. JAMA Intern Med. 2017. PMID: 28055065 Free article. Clinical Trial.
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.
Johnson DW, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM; HONEYPOT Study Collaborative Group. Johnson DW, et al. Among authors: badve sv. Lancet Infect Dis. 2014 Jan;14(1):23-30. doi: 10.1016/S1473-3099(13)70258-5. Epub 2013 Oct 10. Lancet Infect Dis. 2014. PMID: 24119840 Clinical Trial.
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
Wong ATY, Mannix C, Grantham JJ, Allman-Farinelli M, Badve SV, Boudville N, Byth K, Chan J, Coulshed S, Edwards ME, Erickson BJ, Fernando M, Foster S, Haloob I, Harris DCH, Hawley CM, Hill J, Howard K, Howell M, Jiang SH, Johnson DW, Kline TL, Kumar K, Lee VW, Lonergan M, Mai J, McCloud P, Peduto A, Rangan A, Roger SD, Sud K, Torres V, Vilayur E, Rangan GK. Wong ATY, et al. Among authors: badve sv. BMJ Open. 2018 Jan 21;8(1):e018794. doi: 10.1136/bmjopen-2017-018794. BMJ Open. 2018. PMID: 29358433 Free PMC article. Clinical Trial.
Representativeness of Honeypot Trial Participants to Australasian PD Patients.
HONEYPOT Trial Writing Committee; Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, Liu X, McTaggart S, Morrish AT, Playford G, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW; HONEYPOT Study Collaborative Group. HONEYPOT Trial Writing Committee, et al. Among authors: badve sv. Perit Dial Int. 2017 Sep-Oct;37(5):516-522. doi: 10.3747/pdi.2016.00065. Epub 2016 Dec 1. Perit Dial Int. 2017. PMID: 27935534
Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease.
Wong ATY, Munt A, Allman-Farinelli M, Badve SV, Boudville N, Coolican H, Chandra AN, Coulshed S, Fernando M, Grantham J, Haloob I, Harris DCH, Hawley CM, Holt J, Johnson DW, Kumar K, Lee VW, Lonergan M, Mai J, Rangan A, Roger SD, Saravanabavan S, Sud K, Torres VE, Vilayur E, Zhang JQJ, Rangan GK. Wong ATY, et al. Among authors: badve sv. Nutrients. 2020 Nov 2;12(11):3376. doi: 10.3390/nu12113376. Nutrients. 2020. PMID: 33147804 Free PMC article.
The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial.
Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Isbel NM, Krum H, Pascoe EM, Perkovic V, Scaria A, Tonkin AM, Vergara LA, Hawley CM; BLOCADE Study Collaborative Group. Roberts MA, et al. Among authors: badve sv. Am J Kidney Dis. 2016 Jun;67(6):902-11. doi: 10.1053/j.ajkd.2015.10.029. Epub 2015 Dec 22. Am J Kidney Dis. 2016. PMID: 26717861 Clinical Trial.
Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.
Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, Maggo J, Gray V, De Berardis G, Ruospo M, Natale P, Saglimbene V, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque L, Lloyd A, Ahmad N, Liu Y, Tiv S, Wiebe N, Strippoli GF. Palmer SC, et al. Among authors: badve sv. JAMA. 2016 Jul 19;316(3):313-24. doi: 10.1001/jama.2016.9400. JAMA. 2016. PMID: 27434443
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi SL, Ong ML, Irish AB; FAVOURED Study Team. Viecelli AK, et al. Among authors: badve sv. Nephrology (Carlton). 2016 Mar;21(3):217-28. doi: 10.1111/nep.12573. Nephrology (Carlton). 2016. PMID: 26205903 Free article. Clinical Trial.
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW; HONEYPOT Study Collaborative Group. Zhang L, et al. Among authors: badve sv. Perit Dial Int. 2015 Dec;35(7):712-21. doi: 10.3747/pdi.2014.00206. Epub 2015 Jul 29. Perit Dial Int. 2015. PMID: 26224790 Free PMC article. Clinical Trial.
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
Johnson DW, Pascoe EM, Badve SV, Dalziel K, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM; HERO Study Collaborative Group. Johnson DW, et al. Among authors: badve sv. Am J Kidney Dis. 2015 Jan;65(1):49-57. doi: 10.1053/j.ajkd.2014.06.020. Epub 2014 Aug 10. Am J Kidney Dis. 2015. PMID: 25115616 Clinical Trial.
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
Viecelli AK, Pascoe E, Polkinghorne KR, Hawley C, Paul-Brent PA, Badve SV, Cass A, Heritier S, Kerr PG, Mori TA, Robertson A, Seong HL, Irish AB; FAVOURED study team. Viecelli AK, et al. Among authors: badve sv. BMC Nephrol. 2015 Jun 27;16:89. doi: 10.1186/s12882-015-0089-2. BMC Nephrol. 2015. PMID: 26116581 Free PMC article. Clinical Trial.
Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
Lioufas NM, Pedagogos E, Hawley CM, Pascoe EM, Elder GJ, Badve SV, Valks A, Toussaint ND; on behalf of the IMPROVE-CKD Investigators. Lioufas NM, et al. Among authors: badve sv. Am J Nephrol. 2020;51(3):201-215. doi: 10.1159/000505717. Epub 2020 Feb 5. Am J Nephrol. 2020. PMID: 32023606 Clinical Trial.
The Relationship Between Body Mass Index and Organism-Specific Peritonitis.
Jegatheesan D, Johnson DW, Cho Y, Pascoe EM, Darssan D, Htay H, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Nadeau-Fredette AC. Jegatheesan D, et al. Among authors: badve sv. Perit Dial Int. 2018 May-Jun;38(3):206-214. doi: 10.3747/pdi.2017.00188. Perit Dial Int. 2018. PMID: 29848600
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.
Zhang L, Coombes J, Pascoe EM, Badve SV, Dalziel K, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, On Behalf Of The Hero Study Collaborative Group. Zhang L, et al. Among authors: badve sv. Redox Rep. 2016 Jan;21(1):14-23. doi: 10.1179/1351000215Y.0000000022. Epub 2016 Mar 4. Redox Rep. 2016. PMID: 26083328 Free PMC article.
The HONEYPOT randomized controlled trial statistical analysis plan.
Pascoe EM, Lo S, Scaria A, Badve SV, Beller EM, Cass A, Hawley CM, Johnson DW. Pascoe EM, et al. Among authors: badve sv. Perit Dial Int. 2013 Jul-Aug;33(4):426-35. doi: 10.3747/pdi.2012.00310. Perit Dial Int. 2013. PMID: 23843589 Free PMC article. Clinical Trial.
Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis.
Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW. Htay H, et al. Among authors: badve sv. Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1090-1099. doi: 10.2215/CJN.12321216. Epub 2017 Jun 21. Clin J Am Soc Nephrol. 2017. PMID: 28637862 Free PMC article.
Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset.
Wallace H, Wick J, Ketema DB, Buizen L, Woodward M, Peiris D, Neuen BL, Robertson C, Nelson C, Chalmers J, Badve SV, Kotwal SS, Ronksley P, Gallagher M, Jun M. Wallace H, et al. Among authors: badve sv. Lancet Reg Health West Pac. 2025 Apr 10;57:101541. doi: 10.1016/j.lanwpc.2025.101541. eCollection 2025 Apr. Lancet Reg Health West Pac. 2025. PMID: 40276650 Free PMC article.
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Badve SV, Zhang L, Coombes JS, Pascoe EM, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW; HERO Study Collaborative Group. Badve SV, et al. Can J Kidney Health Dis. 2015 Aug 18;2:33. doi: 10.1186/s40697-015-0066-5. eCollection 2015. Can J Kidney Health Dis. 2015. PMID: 26284153 Free PMC article.
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P; HERO Study Collaborative Group. Gummer J, et al. Among authors: badve sv. Nephrology (Carlton). 2017 Jul;22(7):548-554. doi: 10.1111/nep.12815. Nephrology (Carlton). 2017. PMID: 27171136 Clinical Trial.
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset.
Sasaki T, Buizen L, Harris K, Badve SV, Chalmers J, Gallagher M, Ha JT, Jardine MJ, Ketema DB, Kotwal SS, Neuen BL, Ronksley PE, Wallace H, Yokoo T, Woodward M, Jun M. Sasaki T, et al. Among authors: badve sv. Kidney360. 2026 Feb 1;7(2):312-320. doi: 10.34067/KID.0000000988. Epub 2025 Oct 27. Kidney360. 2026. PMID: 41143921 Free PMC article.
Severe muscle weakness due to hyperkalemia.
Tapiawala S, Badve SV, More N, Shah BV. Tapiawala S, et al. Among authors: badve sv. J Assoc Physicians India. 2004 Jun;52:505-6. J Assoc Physicians India. 2004. PMID: 15645966
Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi LS, Ong LM, Irish AB; FAVOURED study team. Viecelli AK, et al. Among authors: badve sv. Nephrology (Carlton). 2017 Oct;22(10):823-824. doi: 10.1111/nep.12823. Nephrology (Carlton). 2017. PMID: 27188542 No abstract available.
Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.
Bose B, McDonald SP, Hawley CM, Brown FG, Badve SV, Wiggins KJ, Bannister KM, Boudville N, Clayton P, Johnson DW. Bose B, et al. Among authors: badve sv. Clin J Am Soc Nephrol. 2011 Nov;6(11):2657-61. doi: 10.2215/CJN.02200311. Epub 2011 Sep 8. Clin J Am Soc Nephrol. 2011. PMID: 21903989 Free PMC article.